APA aipamena

Yamaguchi, J., Ohka, F., Lushun, C., Motomura, K., Aoki, K., Takeuchi, K., . . . Saito, R. (2023). CD79B Y196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma. Wiley.

Chicago Style aipamena

Yamaguchi, Junya, et al. CD79B Y196 Mutation Is a Potent Predictive Marker for Favorable Response to R‐MPV in Primary Central Nervous System Lymphoma. Wiley, 2023.

MLA aipamena

Yamaguchi, Junya, et al. CD79B Y196 Mutation Is a Potent Predictive Marker for Favorable Response to R‐MPV in Primary Central Nervous System Lymphoma. Wiley, 2023.